Michael S. Seaman
Researcher Next ID · RN-022908
Researcher · Immunology and Microbiology
Beth Israel Deaconess Medical Center
Boston, Israel
- Works count
- 433
- Citation count
- 43,317
- H-index
- 106
- i10-index
- 301
Research interests
Publications
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmc2031364
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Nature · 2019 · https://doi.org/10.1038/s41586-019-1250-z
An immunogenic personal neoantigen vaccine for patients with melanoma
Nature · 2017 · https://doi.org/10.1038/nature22991
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1
Science · 2016 · https://doi.org/10.1126/science.aaf0972
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies
Journal of Virology · 2013 · https://doi.org/10.1128/jvi.02853-13
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Nature · 2013 · https://doi.org/10.1038/nature12744
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization
Cell · 2013 · https://doi.org/10.1016/j.cell.2013.03.018
Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors
Journal of Virology · 2011 · https://doi.org/10.1128/jvi.05045-11
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Science · 2011 · https://doi.org/10.1126/science.1207227
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Science · 2010 · https://doi.org/10.1126/science.1187659
Current projects
No projects listed.